Special Offers & Promotions



Latest News



View Channel

New Products



View Channel

Video Presentations



View Channel

Separation Science



View Channel

Microscopy & Image Analysis



View Channel

Laboratory Automation & IT Solutions



View Channel


Agilent Announces AssayMAP Bravo Protein Sample Prep Workbench 4.0

publication date: Dec 6, 2022
author/source: Agilent Technologies

Launch extends the use of AssayMAP to regulated environments

Agilent Technologies Inc. has announced the release of the AssayMAP Bravo Protein Sample Prep Workbench 4.0 software. This release adds 21 CFR Part 11 compliance-enabling features that allow AssayMAP Bravo-based automated sample preparation in workflows across the biopharma drug development process. 

The requirement for labs to use instruments that comply with regulatory guidelines such as 21 CFR Part 11 or have the option of turning on compliance-enabling software features is moving to earlier stages of the drug development process. The AssayMAP Workbench 4.0 addresses these requirements and facilitates the seamless transfer of assays along the entire drug development process, including moving from non-compliant to compliant laboratories.

AssayMAP Workbench 4.0 simplifies the documentation required in regulated laboratories and desired in non-regulated labs by providing the option to generate reports that capture sample prep workflow data. The new AssayMAP software enables novice users to use the system with minimal training by providing a walk-up operation option. 

“The addition of compliance enabling features, walk-up capabilities, and report generation provide our customers added value across the entire biopharma drug development process,” said Lars Kristiansen, general manager of Agilent’s Automation Solutions business. “These enhancements align with our focus to provide new solutions to our biopharma partners that enable them to bring biotherapeutics to market faster and more cost-effectively.” 

AssayMAP Workbench 4.0 also expands software support for the recently released AssayMAP large-capacity cartridges. These cartridges enhance the ability of biopharma labs to analyze biotherapeutic critical quality attributes and enable more complete automation of sample prep workflows.
About Agilent Technologies


About Agilent Technologies Inc

Agilent Technologies Inc. (NYSE: A) is a global leader in the life sciences, diagnostics, and applied chemical markets, delivering insight and innovation that advance the quality of life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.32 billion in fiscal 2021 and employs 17,000 people worldwide.


Recent news from Agilent


If you have not logged into the website then please enter your details below.


Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin


Request your free copies HERE




Popular this Month

Top 10 most popular articles this month



Today's Picks



Looking for a Supplier?

Search by company or by product


Company Name:






Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


Media Partners


Exhibitions & Events